Dredge, K., Hammond, E., Handley, P., Gonda, T. J., Smith, M. T., Vincent, C., . . . Bytheway, I. (2011). PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Nature Publishing Group.

Dredge, K., E. Hammond, P. Handley, T J. Gonda, M T. Smith, C. Vincent, R. Brandt, V. Ferro, and I. Bytheway. PG545, a Dual Heparanase and Angiogenesis Inhibitor, Induces Potent Anti-tumour and Anti-metastatic Efficacy in Preclinical Models. Nature Publishing Group, 2011.

Dredge, K., et al. PG545, a Dual Heparanase and Angiogenesis Inhibitor, Induces Potent Anti-tumour and Anti-metastatic Efficacy in Preclinical Models. Nature Publishing Group, 2011.